0000899243-17-005263.txt : 20170224
0000899243-17-005263.hdr.sgml : 20170224
20170224183640
ACCESSION NUMBER: 0000899243-17-005263
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170224
FILED AS OF DATE: 20170224
DATE AS OF CHANGE: 20170224
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Aimmune Therapeutics, Inc.
CENTRAL INDEX KEY: 0001631650
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 452748244
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 8000 MARINA BOULEVARD
STREET 2: SUITE 300
CITY: BRISBANE
STATE: CA
ZIP: 94005-1884
BUSINESS PHONE: (650) 614-5220
MAIL ADDRESS:
STREET 1: 8000 MARINA BOULEVARD
STREET 2: SUITE 300
CITY: BRISBANE
STATE: CA
ZIP: 94005-1884
FORMER COMPANY:
FORMER CONFORMED NAME: Allergen Research Corp
DATE OF NAME CHANGE: 20150123
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Barrowcliffe Susan E.
CENTRAL INDEX KEY: 0001664251
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37519
FILM NUMBER: 17639021
MAIL ADDRESS:
STREET 1: 8000 MARINA BOULEVARD, SUITE 300
CITY: BRISBANE
STATE: CA
ZIP: 94005-1884
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2017-02-24
0
0001631650
Aimmune Therapeutics, Inc.
AIMT
0001664251
Barrowcliffe Susan E.
AIMMUNE THERAPEUTICS, INC.
8000 MARINA BOULEVARD, SUITE 300
BRISBANE
CA
94005-1884
0
1
0
0
General Manager, Europe
Stock Option (right to buy)
19.63
2017-02-24
4
A
0
90000
0.00
A
2027-02-24
Common Stock
90000
90000
D
The shares subject to the option will vest and become exercisable as to one-forty-eighth (1/48th) of the total number of shares subject to the option in successive, equal monthly installments measured from February 24, 2017, subject to the Reporting Person's continued service relationship with the Issuer on each such vesting date.
/s/ Warren L. DeSouza, as Attorney in Fact for Susan E. Barrowcliffe
2017-02-24